Work

Abstract PS2-02-06: Benefit of adjuvant chemotherapy for early-stage hormone receptor positive and HER2 negative lobular breast cancer patients: Analysis based on genomic risk scores

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps2-02-06

Authors: A. Roy, Y. Gokun, B. Slover, N. Lopetegui-Lia, D. Quiroga, G. Bader, M. Cherian, A. Davenport, K. Johnson, S. Sardesai, R. Wesolowski, S. Myers, E. Burke, M. Gatti-Mays, N. Williams, D. Stover

Institution: The Ohio State University

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129722003

Cites:

Cited by:

Related to: